Alps Advisors Inc Fortress Biotech, Inc. Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.8 - $1.5 $81,920 - $153,600	-102,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $15,992 - $35,466	-12,897 Reduced 11.19%	102,400 $139,000
Q4 2021 Feb 09, 2022	SELL	$2.42 - $3.65 $18,152 - $27,378	-7,501 Reduced 6.11%	115,297 $288,000
Q3 2021 Nov 15, 2021	SELL	$2.82 - $3.7 $15,168 - $19,902	-5,379 Reduced 4.2%	122,798 $395,000
Q2 2021 Aug 11, 2021	SELL	$3.5 - $5.48 $144,721 - $226,592	-41,349 Reduced 24.39%	128,177 $458,000
Q1 2021 May 07, 2021	BUY	$3.16 - $4.89 $37,780 - $58,464	11,956 Added 7.59%	169,526 $598,000
Q4 2020 Feb 03, 2021	BUY	$2.2 - $4.45 $346,654 - $701,186	157,570 New	157,570 $499,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $254M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.